Hepatitis B Vaccine Recommended for Infants Within 24 Hours of Birth
The vaccine is 75% to 95% effective in preventing perinatal hepatitis B transmission when given within 24 hours of birth, according to the AAP policy statement.
Read More
Liver Cancer Risks Not Affected by Hepatitis C Eliminating Therapy
Yuko Nagaoki and colleagues at Hiroshima University compared the occurrence of hepatocellular carcinoma in HCV patients cured with direct acting antivirals and those given interferon therapy.
Baby Boomers Increase HCV Screenings, Treatment When Alert Added to Health Records
An electronic health records prompt that reminds primary care providers to recommend testing has aided in an entire generations' lacking of hepatitis C screening, according to a new study.
Viral Hepatitis Up to 10 Times More Likely in Indigenous Populations
Poverty and poor healthcare raise the trending global risks.
Eat Your Broccoli: Vegetable-Derived Compound Shows Promise for Type 2 Diabetes
Sulforaphane has been found to lower glucose production and improve control in T2D patients.
Gestational Diabetes Risk Linked to Weight Gain Between Pregnancies
A recent study suggests that weight change should be considered in GDM screening for pregnant mothers.
HCV Drug Receives Australian Subsidy as Nation Aims for Zero Infections
Could US leaders in government and health care follow the same route?
Alcohol Consumption Linked to Reduction in Diabetes Risk
Consuming alcohol 3-4 times per week was associated with a 27% decrease in men's risk, and 32% decrease in women's.
Rodents Provide Possible Breakthrough Toward Hepatitis C Vaccine
A form of the virus was isolated From New York City rats.
Hepatitis C Cure Rate Tops 90% in Hard-to-Treat Genotype 3 Patients
The sofosbuvir-based therapy was reviewed in a real-life Scandinavian study
Hepatitis C Patients Attaining SVR With Antiviral Drugs Show Reduced Liver Cancer Risk
Data on HCC risk following DAA-induced SVR are still "sparse and conflicting," the authors wrote.
Study of Antiviral Hepatitis C Treatment Shows Near Universal SRV
The individuals in the study were all members of Israel’s Clalit Health Services in Tel Aviv, where more than 4.3 million people are enrolled.
Fruitful Study: Compound in Plums Inhibits Hepatitis C Virus Entry
A flavonoid called rutin inhibited HCV-like particles from binding to hepatoma cells and inhibited HCV from entering the cells during the virus’s initial entry stage.
Eliminating Hepatitis C with Antiviral Drugs Improves Diabetes Control, Study Finds
Eradicating the hepatitis C virus (HCV) with direct-acting antiviral (DAA) drugs improves the control of glucose levels in patients with type 2 diabetes (T2D), a new study suggests.
Two-drug Therapy for HCV Patients Matches SVR Results Shown in Clinical Trials
The results of the Korea-based study of the two-drug combination therapy showed a significant sustained virologic response rate over 12 weeks.
HCV Patients Who Inject Drugs Show Treatment Adherence Similar to Non-Users, Study Finds
The Ireland-based study observed the results of a 10-year treatment program.
Hepatitis C Elimination Hinges on Improved Monitoring, Modest Investment, Report Says
Surveillance and monitoring are key to eliminating the hepatitis C virus – and even modest investments can improve lives and save money, a new report concludes.
Hepatitis C Clinic in India Treating Patients for Free in Doctors Without Borders Project
A new clinic that treats hepatitis C in India’s most populous state has provided 356 patients with direct-acting antiviral drugs free of charge.
US Liver Cancer Mortality Rates Double Since 1980s
A new study cites hepatitis C infections among baby boomers as a chief culprit in liver cancer’s rise.
Study Questions Long-Term Outcomes of Direct-Acting Antivirals in Treating Hepatitis C
Study looks at whether DAA drugs eliminate HCV from the body or improve survival.
DAA Treatment Lowers Need for Liver Transplants, Study Shows
Only 3% of those in the study who received sofosbuvir needed a transplant.
Researchers Identify Gaps in European Hepatitis Testing
The study is part of an effort to determine a starting point to act against viral hepatitis.
New Hepatitis C Combination Pill Targets Hard-to-Treat Patients
The once-a-day medication consists of direct-acting antiviral (DAA) sofosbuvir (Sovaldi/Gilead Sciences Inc.) along with voxilaprevir and velpatasvir.
HCV Reinfection Uncommon Among Patients on Opioid Substitution Therapy After DAA Treatment, Study Suggests
Direct-acting antiviral medication impacts HCV infection in patients on opioid substitution therapy.
Genetic Markers May Predict Which HCV/Cirrhosis Patients Improve with Treatment
Findings could minimize the need for liver transplants.
Generic Hepatitis C Drugs in India Prove Cost-Effective While Boosting Patient Outcomes
DAAs Cost $1309 Less Over Lifetime Than Providing No Treatment
Study Suggests New Way to Fight Hepatitis C, Other Infections
Researchers studied how the virus hijacks infected cells.
Hepatitis C Guide Released in Time for National Testing Day
The guide calls for Baby Boomers to be tested at least once in their lives.
HCV Eliminated in Patients Given Kidney Transplants from Infected Donors
Patients who received lifesaving kidney transplants from deceased donors infected with HCV were cured after undergoing antiviral drug therapy.
Hepatitis B and C Affect 325 Million Worldwide with Most Failing to Get Treatment, WHO Says
WHO estimates 325 million people worldwide are living with chronic HBV or HCV.